Abnormal nuchal translucency: residual risk with normal cell-free DNA screening.

To determine the proportion of genetic abnormalities that could be identified by cell-free DNA screening in pregnancies with an abnormal nuchal translucency. From 2015-2017, pregnancies with nuchal translucency ≥ 3.0 mm on ultrasounds were identified.